4:04pm ET
Investing
JD.com, Exelixis Stumble into Monday’s 52-Week Low Club
JD.com, Turquoise Hills, Exelixis, and Floor & Decor Holdings all posted new 52-week lows Monday.
Companies
/Healthcare
Exelixis Inc
$56.12
▼ $1.31 (−2.28%) today
Markets closed · 4:40am ET
EXEL Coverage
Page 2
4:04pm ET
Investing
Invesco, Chemours Slide into Thursday’s 52-Week Low Club
Invesco, Tal Education, Chemours, and Exelixis all posted new 52-week lows on Thursday.
4:04pm ET
Investing
Sears, Exelixis Fall into Tuesday’s 52-Week Low Club
SeaChange, Sears, Exelixis, and Adamis Pharma all posted new 52-week lows Tuesday.
4:04pm ET
Investing
Exelixis, Lannett Topple into Monday’s 52-Week Low Club
Lannett Co., Scorpio Tankers, Mobile Telesystems, and Exelixis all posted new 52-week lows Monday.
8:20am ET
Health and Healthcare
4 Red-Hot Biotech Stocks to Buy Before Earnings
These four top Suntrust biotech picks for 2018 all have the potential for big upside moves if they do indeed exceed first-quarter expectations.
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Albermarle, Best Buy, Chipotle, Exact Sciences, Fitbit, Itron, NuVasive, Palo Alto Networks, Stryker and More
The include Albermarle, Best Buy, Chipotle Mexican Grill, Exact Sciences, Fitbit, Itron, NuVasive, Palo Alto Networks and Stryker.
11:35am ET
Health and Healthcare
Exelixis Slides Despite Positive Late-Stage Results
Shares of Exelixis slipped on Wednesday after the company reported results from its late-stage trial of cabozantinib for advanced hepatocellular carcinoma.
Chris Lange 1:45pm ET
Health and Healthcare
Exelixis Wins Big With FDA Approval
Exelixis saw its shares make a handy gain on Wednesday after the company received the nod from the FDA for Cabometyx tablets.
Chris Lange 8:15am ET
Investing
9 Major Stock Movers to Watch for Wednesday
With tax reform having cleared the Senate and going back to the House, investors were looking for a higher stock market open on Wednesday.
9:10am ET
Health and Healthcare
Exelixis Cancer Treatment Hits Key Milestone
Exelixis kicked off the week with a couple updates that are already having a big impact on the stock. These updates came in the form of a key FDA approval.
Chris Lange 10:25am ET
Health and Healthcare
4 Biotech Stocks to Buy That May See Huge Volatility From Earnings
Some of the top biotech stocks could become extremely volatile before and after earnings. These four that may be worth a look for aggressive investors.
9:30am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, CVS Health, Priceline, Teva Pharmaceuticals, Workday and Many More
Tuesday’s top analyst upgrades, downgrades and initiations include Apple, CVS Health, Priceline, Teva Pharmaceutical and Workday.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Brocade, Facebook, First Solar, Fitbit, ONEOK Partners, Sunrun and More
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Brocade Communications Systems, Facebook, First Solar, Fitbit, ONEOK Partners and Sunrun.
8:40am ET
Health and Healthcare
Exelixis Continues Massive Run With Positive Cabosun Results
Shares of Exelixis saw a handy gain early Monday morning after the company reported positive results from its mid-stage trial for the treatment of renal cell carcinoma.
Chris Lange 9:15am ET
Health and Healthcare
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.